ZNTL

1.43

0.69% -0.01

Handel nachbörslich: 1.43

Zentalis Pharmaceuticals Inc (ZNTL)

Überblick Nachrichten Preisverlauf Optionskette Financials Warum fällt ZNTL? Forum Prognose

Schlusskurs vom Vortag:

$1.44

Offen:

$1.44

24-Stunden-Volumen:

289.00K

Relative Volume:

0.43

Marktkapitalisierung:

$103.32M

Einnahmen:

Nettoeinkommen (Verlust:

$-292.19M

KGV:

-0.315

EPS:

-4.54

Netto-Cashflow:

$-208.41M

1W Leistung:

+6.72%

1M Leistung:

-16.37%

6M Leistung:

+14.40%

1J Leistung:

-60.61%

1-Tages-Spanne:

$1.42

$1.46

1-Wochen-Bereich:

$1.3314

$1.46

52-Wochen-Spanne:

$1.01

$4.00

Zentalis Pharmaceuticals Inc Stock (ZNTL) Company Profile

Firmenname

Zentalis Pharmaceuticals Inc

Sektor

Healthcare (1137)

Branche

Biotechnology (638)

Telefon

(858) 263-4333

Adresse

10275 SCIENCE CENTER DRIVE, SAN DIEGO, NY

Mitarbeiter

166

Twitter

@ZentalisP

Nächster Verdiensttermin

2025-03-26

Neueste SEC-Einreichungen

ZNTL's Discussions on Twitter

Vergleichen Sie ZNTL mit anderen Aktien

Aktien	Preis	Marktkapitalisierung	Umsatz	Nettogewinn	Free Cashflow	ENV
ZNTL Zentalis Pharmaceuticals Inc	1.43	104.04M	0	-292.19M	-208.41M	-4.54
VRTX Vertex Pharmaceuticals Inc	433.61	109.65B	11.74B	3.68B	3.34B	14.19
REGN Regeneron Pharmaceuticals Inc	780.19	82.46B	14.25B	4.58B	3.88B	41.77
ALNY Alnylam Pharmaceuticals Inc	451.23	58.81B	3.21B	43.57M	221.36M	0.2405
ARGX Argen X Se Adr	911.98	56.50B	3.06B	1.28B	447.35M	19.67
INSM Insmed Inc	207.77	43.62B	447.02M	-1.18B	-906.14M	-6.1812

Zentalis Pharmaceuticals Inc Stock (ZNTL) Upgrades & Downgrades

Datum	Aktion	Analytiker	Ratingänderung
2024-08-12	Hochstufung	Wedbush	Underperform → Neutral
2024-06-20	Herabstufung	UBS	Buy → Neutral
2024-06-18	Herabstufung	Jefferies	Buy → Hold
2024-06-18	Herabstufung	Morgan Stanley	Overweight → Equal-Weight
2024-06-18	Herabstufung	Wedbush	Neutral → Underperform
2024-06-18	Herabstufung	Wells Fargo	Overweight → Equal Weight
2023-11-08	Herabstufung	Wedbush	Outperform → Neutral
2023-11-07	Herabstufung	Leerink Partners	Outperform → Market Perform
2022-07-12	Eingeleitet	Cowen	Outperform
2022-04-06	Eingeleitet	Wells Fargo	Overweight
2021-10-07	Fortgesetzt	Jefferies	Buy
2021-09-30	Eingeleitet	Stifel	Buy
2021-09-29	Eingeleitet	Oppenheimer	Outperform
2021-05-21	Eingeleitet	UBS	Buy
2021-01-20	Eingeleitet	Wedbush	Outperform
2020-09-29	Eingeleitet	Cantor Fitzgerald	Overweight
2020-08-27	Eingeleitet	H.C. Wainwright	Buy
2020-04-28	Eingeleitet	Guggenheim	Buy
2020-04-28	Eingeleitet	Jefferies	Buy
2020-04-28	Eingeleitet	Morgan Stanley	Overweight
2020-04-28	Eingeleitet	SVB Leerink	Outperform

Alle ansehen

Zentalis Pharmaceuticals Inc Aktie (ZNTL) Neueste Nachrichten

Nov 29, 2025

Why Zentalis Pharmaceuticals Inc. stock is favored by top institutions2025 Valuation Update & Weekly High Conviction Ideas - BỘ NỘI VỤ

Nov 29, 2025

Nov 27, 2025

What analysts say about Zentalis Pharmaceuticals Inc stockTake Profit Strategies & Affordable Trading Growth - earlytimes.in

Nov 27, 2025

Is Zentalis Pharmaceuticals Inc. stock trading near support levels2025 Pullback Review & Long-Term Growth Stock Strategies - BỘ NỘI VỤ

Nov 27, 2025

Nov 25, 2025

Zentalis Pharmaceuticals Forms Death Cross, Signaling Bearish Trend Ahead - Markets Mojo

Nov 25, 2025

Nov 21, 2025

Perhaps timely catching Zentalis Pharmaceuticals Inc (ZNTL) would be a good idea - Setenews

Nov 21, 2025

Connor Clark & Lunn Investment Management Ltd. Decreases Stake in Zentalis Pharmaceuticals, Inc. $ZNTL - Defense World

Nov 21, 2025

Nov 20, 2025

Zentalis Pharmaceuticals (ZNTL) Price Target Decreased by 14.14% to 5.42 - MSN

Nov 20, 2025

Nov 19, 2025

What indicators show strength in Zentalis Pharmaceuticals Inc.Portfolio Growth Summary & Accurate Entry and Exit Point Alerts - newser.com

Nov 19, 2025

Is Zentalis Pharmaceuticals Inc. stock in correction or buying zoneMarket Volume Summary & Free Verified High Yield Trade Plans - newser.com

Nov 19, 2025

Why analysts upgrade Zentalis Pharmaceuticals Inc. stockEarnings Performance Report & Weekly Setup with High ROI Potential - newser.com

Nov 19, 2025

Why Zentalis Pharmaceuticals Inc. stock is in analyst buy zone2025 Analyst Calls & AI Driven Stock Reports - newser.com

Nov 19, 2025

Nov 18, 2025

Is Zentalis Pharmaceuticals Inc. forming a bottoming base2025 Top Decliners & Reliable Price Breakout Alerts - newser.com

Nov 18, 2025

Zentalis Pharmaceuticals: Hanging On For One Last Shot At PROC Approval (ZNTL) - Seeking Alpha

Nov 18, 2025

Nov 16, 2025

Multi asset correlation models including Zentalis Pharmaceuticals Inc.Earnings Beat & Weekly High Conviction Trade Ideas - newser.com

Nov 16, 2025

How geopolitical tensions affect Zentalis Pharmaceuticals Inc. stockBuy Signal & Momentum Based Trading Ideas - newser.com

Nov 16, 2025

Wall Street Zen Upgrades Zentalis Pharmaceuticals (NASDAQ:ZNTL) to Hold - Defense World

Nov 16, 2025

Nov 15, 2025

Can Zentalis Pharmaceuticals Inc. stock reach $100 price target2025 Key Highlights & Weekly High Return Stock Opportunities - newser.com

Nov 15, 2025

Nov 14, 2025

FY2025 Earnings Estimate for ZNTL Issued By Leerink Partnrs - Defense World

Nov 14, 2025

What is HC Wainwright’s Estimate for ZNTL FY2025 Earnings? - Defense World

Nov 14, 2025

Zentalis Pharmaceuticals, Inc. (NASDAQ:ZNTL) Receives Average Rating of “Hold” from Analysts - Defense World

Nov 14, 2025

Wedbush Reiterates “Neutral” Rating for Zentalis Pharmaceuticals (NASDAQ:ZNTL) - Defense World

Nov 13, 2025

Morgan Stanley Maintains Zentalis Pharmaceuticals (ZNTL) Equal-Weight Recommendation - MSN

Nov 13, 2025

Nov 12, 2025

Relative strength of Zentalis Pharmaceuticals Inc. in sector analysisPortfolio Return Summary & Risk Adjusted Buy and Sell Alerts - newser.com

Nov 12, 2025

ZNTL Stock Update: Morgan Stanley Lowers Price Target by 50% | Z - GuruFocus

Nov 12, 2025

What recovery options are there for Zentalis Pharmaceuticals Inc.2025 Pullback Review & Short-Term Trading Opportunity Alerts - newser.com

Nov 12, 2025